This compound is a phosphoramidite reagent used in the solid-phase synthesis of oligonucleotides. It serves as a key building block for incorporating modified nucleotides into synthetic DNA or RNA sequences.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 98796-53-3
Ac-dA Phosphoramidite
pharmaceutical intermediate
N-[9-[(2R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenyl-methoxy]methyl]-4-[2-cyanoethoxy-(diisopropylamino)phosphanyl]oxy-3,3-difluoro-tetrahydrofuran-2-yl]purin-6-yl]benzamide
research compound
N-Benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-5-methyl-cytidine 3'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]
pharmaceutical intermediate
(2R,3R,4R,5R)-5-(6-Benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-(hexadecyloxy)tetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
pharmaceutical intermediate
2'-O-MOE-5-Methyl-Uridine Phosphoramidite
pharmaceutical intermediate
1-(Cyanomethyl)imidazole
pharmaceutical intermediate
1-Boc-3-piperidone
pharmaceutical intermediate
1-(3-chlorophenyl)ethanone
pharmaceutical intermediate
N-[9-[(2R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxyoxolan-2-yl]purin-6-yl]benzamide
GGDNKEQZFSTIMJ-AKWFTNRHSA-N
CC(C)N(C(C)C)P(OCCC#N)O[C@H]1C[C@@H](O[C@@H]1COC(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)C4=CC=C(C=C4)OC)N5C=NC6=C(N=CN=C65)NC(=O)C7=CC=CC=C7